I do agree with everyone here, not a fan of the way they report.
The growth is not where I'd like it to be but I'm still confident we will get there now that covid is steadily improving.
Still think it's undervalued, especially when looking at other biotechs at similar market caps.
- Forums
- ASX - By Stock
- Ann: Q1 FY22 Trading Update - Clarification Announcement
I do agree with everyone here, not a fan of the way they report....
-
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.06 |
Change
0.010(0.49%) |
Mkt cap ! $1.422B |
Open | High | Low | Value | Volume |
$2.07 | $2.08 | $2.02 | $1.464M | 714.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4237 | $2.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.07 | 15041 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4237 | 2.060 |
1 | 6116 | 2.050 |
2 | 11116 | 2.040 |
2 | 30240 | 2.030 |
4 | 8429 | 2.020 |
Price($) | Vol. | No. |
---|---|---|
2.070 | 15041 | 1 |
2.080 | 21170 | 4 |
2.090 | 76116 | 2 |
2.100 | 17093 | 3 |
2.110 | 33311 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online